Reaction
Colorectal Cancer Recurrent reporting signals
As of the last recalculation, Colorectal Cancer Recurrent appears in 127 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is PANITUMUMAB (PRR 525.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Panitumumab | 36 | 525.3 | 526.5 |
| Regorafenib | 13 | 204.3 | 204.6 |
| Trifluridine And Tipiracil | 7 | 113.1 | 113.2 |